Signal from the log
Saliviq Diagnostics
1 911 999 $ · United States
SalivIQ Diagnostics met au point un test salivaire de l'angine à streptocoque, lu par PCR quantitative, pour remplacer le prélèvement de gorge au coton tige. La société vise une autorisation de la FDA. Son dépôt SEC ne nomme aucun fonds.
Spotted Amount read from the headline
Announced on , logged by the watch of 23 September 2026.
- Operation
- Funding round
- Announced amount
- 1 911 999 $
- Country
- United States
What the log says
Editorial note, in French
Dépôt réglementaire repéré à la SEC. Le tour n'est pas encore documenté publiquement, aucun fonds n'y est nommé.
- No fund is publicly named. It is the first condition of the selection bar: without a named investor there is no round to tell.
- The amount shown is an automatic reading of the source headline, not a reading of the press release. It is not verified yet.
- The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.